Imaging and quantification of myocardial scars using reduced contrast dose in late-gadolinium enhancement technique by cardiovascular MRI (TWIN-CMR)

Charité - University Medicine Berlin0 个研究点目标入组 280 人开始时间: 2021年9月20日最近更新: 2021年10月4日

适应症

试验速览

暂无简介。

•1. Written consent of the patient prior to commencement of study-specific actions
•2. Capable of giving consent and capable of understanding the nature and scope of the clinical trial
•3. Aged =18 years
•4. Confirmed diagnosis or suspected diagnosis of acute or chronic myocardial infarction, inflammatory heart disease, or hypertrophic cardiomyopathy
•5. Clinically indicated cardiac MRI examination with gadolinium-containing contrast agent according to the disease present

•1. Absolute contraindication to MRI examination (e.g. presence of metal implants, insulin pumps, pacemakers, ICDs, orbital foreign bodies, non-MRI cochlear implants, cerebral vascular clips)
•2. Known allergy to MRI contrast media
•3. Pregnant or breastfeeding
•4. Have already participated in this study
•5. Refusal to participate
•6. Not capable of giving consent

发起方